SG52313A1 - 1A, 24-(OH)2-V.D3 emulsion composition - Google Patents

1A, 24-(OH)2-V.D3 emulsion composition

Info

Publication number
SG52313A1
SG52313A1 SG1996002669A SG1996002669A SG52313A1 SG 52313 A1 SG52313 A1 SG 52313A1 SG 1996002669 A SG1996002669 A SG 1996002669A SG 1996002669 A SG1996002669 A SG 1996002669A SG 52313 A1 SG52313 A1 SG 52313A1
Authority
SG
Singapore
Prior art keywords
weight
parts
oil component
surfactants
alcohol
Prior art date
Application number
SG1996002669A
Other languages
English (en)
Inventor
Yuji Makino
Hideo Matugi
Yoshiki Suzuki
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Publication of SG52313A1 publication Critical patent/SG52313A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)
SG1996002669A 1993-09-01 1994-09-01 1A, 24-(OH)2-V.D3 emulsion composition SG52313A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21726193 1993-09-01

Publications (1)

Publication Number Publication Date
SG52313A1 true SG52313A1 (en) 1998-09-28

Family

ID=16701374

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996002669A SG52313A1 (en) 1993-09-01 1994-09-01 1A, 24-(OH)2-V.D3 emulsion composition

Country Status (17)

Country Link
US (1) US5612327A (ko)
EP (1) EP0667166B1 (ko)
JP (1) JP3045179B2 (ko)
KR (1) KR100221045B1 (ko)
CN (1) CN1082818C (ko)
AT (1) ATE195431T1 (ko)
CA (1) CA2148109C (ko)
CZ (1) CZ284261B6 (ko)
DE (1) DE69425552T2 (ko)
DK (1) DK0667166T3 (ko)
ES (1) ES2148340T3 (ko)
NO (1) NO312227B1 (ko)
PL (1) PL175492B1 (ko)
PT (1) PT667166E (ko)
SG (1) SG52313A1 (ko)
SK (1) SK279913B6 (ko)
WO (1) WO1995006482A1 (ko)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763429A (en) * 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
US6242434B1 (en) * 1997-08-08 2001-06-05 Bone Care International, Inc. 24-hydroxyvitamin D, analogs and uses thereof
KR100387156B1 (ko) 1995-04-21 2003-10-11 세키스이가가쿠 고교가부시키가이샤 피부질환치료용외용제
DE19639816A1 (de) * 1996-09-27 1998-04-02 Hoechst Ag Antimykotische Mittel mit hoher Wirkstofffreisetzung
US20040039030A1 (en) * 1996-09-27 2004-02-26 Hoechst Akeengesellschaft Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
US20020128240A1 (en) * 1996-12-30 2002-09-12 Bone Care International, Inc. Treatment of hyperproliferative diseases using active vitamin D analogues
US6566353B2 (en) * 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
US20030129194A1 (en) * 1997-02-13 2003-07-10 Bone Care International, Inc. Targeted therapeutic delivery of vitamin D compounds
US6087350A (en) * 1997-08-29 2000-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
ES2245511T3 (es) 1998-03-04 2006-01-01 Teijin Limited Lociones de vitamina d3 activa en forma de emulsion.
AU762481C (en) * 1998-03-27 2004-08-19 Oregon Health Sciences University Vitamin D and its analogs in the treatment of tumors and other hyperproliferative disorders
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
IL153378A0 (en) * 2000-07-18 2003-07-06 Bone Care Internat Inc STABILIZED 1alpha-HYDROXY VITAMIN D
US20030191093A1 (en) * 2001-12-03 2003-10-09 Novacea, Inc. Pharmaceutical compositions comprising active vitamin D compounds
US20050026877A1 (en) * 2002-12-03 2005-02-03 Novacea, Inc. Pharmaceutical compositions comprising active vitamin D compounds
US20060189586A1 (en) * 2003-06-11 2006-08-24 Cleland Jeffrey L Pharmaceutical compositions comprising active vitamin D compounds
US20050020546A1 (en) * 2003-06-11 2005-01-27 Novacea, Inc. Pharmaceutical compositions comprising active vitamin D compounds
US7534894B2 (en) 2003-09-25 2009-05-19 Wyeth Biphenyloxy-acids
US7094775B2 (en) * 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
US20060003950A1 (en) * 2004-06-30 2006-01-05 Bone Care International, Inc. Method of treating prostatic diseases using a combination of vitamin D analogues and other agents
ES2407407T3 (es) 2005-06-01 2013-06-12 Glaxosmithkline Intellectual Property Development Limited Formulación de vitamina

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1272953A (en) * 1984-10-08 1990-08-21 Yuji Makino Pharmaceutical composition for external use containing active-type vitamin d.sub.3
JPS6226223A (ja) * 1985-07-25 1987-02-04 Teijin Ltd 乾癬治療剤
JPH0774144B2 (ja) * 1986-03-12 1995-08-09 久光製薬株式会社 尿素を含有する皮膚用組成物
GB9226860D0 (en) * 1992-12-23 1993-02-17 Leo Pharm Prod Ltd Novel treatment

Also Published As

Publication number Publication date
CA2148109C (en) 1999-11-23
SK279913B6 (sk) 1999-05-07
DK0667166T3 (da) 2000-10-16
SK59295A3 (en) 1995-12-06
DE69425552D1 (de) 2000-09-21
CN1114824A (zh) 1996-01-10
JP3045179B2 (ja) 2000-05-29
CA2148109A1 (en) 1995-03-09
KR950703998A (ko) 1995-11-17
PT667166E (pt) 2001-02-28
EP0667166A1 (en) 1995-08-16
CN1082818C (zh) 2002-04-17
PL308748A1 (en) 1995-08-21
NO951639L (no) 1995-06-30
ATE195431T1 (de) 2000-09-15
CZ113295A3 (en) 1995-11-15
KR100221045B1 (ko) 1999-09-15
WO1995006482A1 (fr) 1995-03-09
DE69425552T2 (de) 2001-04-19
CZ284261B6 (cs) 1998-10-14
EP0667166B1 (en) 2000-08-16
NO312227B1 (no) 2002-04-15
EP0667166A4 (en) 1995-11-02
ES2148340T3 (es) 2000-10-16
US5612327A (en) 1997-03-18
NO951639D0 (no) 1995-04-28
PL175492B1 (pl) 1999-01-29

Similar Documents

Publication Publication Date Title
SG52313A1 (en) 1A, 24-(OH)2-V.D3 emulsion composition
AU597822B2 (en) Transparent antiperspirant stick compositions
EP0391124A3 (en) Cosmetic composition of double emulsion type
AR015101A1 (es) Una composicion limpiadora liquida en microemulsion que contiene un agente acaricida
KR870004699A (ko) 피부를 촉촉하게 하는 미세유화액 조성물
AU3368789A (en) Human growth hormone formulation
AU4276896A (en) Controlled release composition forming a reversed micellar (l2) structure or a normal micellar (l1) structure
AU576278B2 (en) Topical antibacterial cream comprising an iodophor in an oil in water emulsion
KR850006321A (ko) 화장용 유제
GB2004746A (en) Compositions containing benzocaine
AU4607589A (en) Antiperspirant compositions
AU3232989A (en) Skin moisturizing composition and method of preparing same
GB9302492D0 (en) Cosmetic compositions
AU2968089A (en) Emulsion compositions including amphipathic emulsifying agents
AU8455091A (en) Edible fats and oils stabilized with sesame oil as a constituent
MX9500133A (es) Emulsiones de agua/aceite de alta fase interna.
FR2706298B1 (fr) Composition cosmétique ou dermatologique sous forme d'une émulsion huile-dans-l'eau stable contenant au moins une huile végétale constituée d'au moins 40% de triglycérides d'acide linoléique.
JPS5653608A (en) Emulsified stick cosmetic
AU6922891A (en) Improvements in or relating to topical compositions containing 1 alpha 25-dihydroxycholecalciferol
EP0211555A3 (en) Transparent silicone compositions
AU2045888A (en) Composition for external use containing capped ethoxylate
JPS56154408A (en) Oil-in-water type emulsion composition
JPS5531036A (en) Improved skin cream
JPS647939A (en) Oil-in-water type emulsion composition